IP Library Granted Patent US 12,397,071
Granted Patent B2
US 12,397,071 · App. 18/240,984 · Granted Aug 26, 2025

Anti-microbial blue light systems and methods

Inventors: Robert A. Rabiner (Dortmund, DE); Liane J. Rabiner (Dortmund, DE); Gene P. DiPoto (Upton, MA); Anthony W. O'Leary (Walpole, MA); Michael P. Mogul (San Diego, CA)
Assignee: ABL Medical Inc.
A61L2/0052A61L2/084A61L2/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,397,071
App. No.
18/240,984
Granted
Aug 26, 2025
Kind
B2
Abstract

Systems, devices and methods for controlled intramedullary delivery of light (frequencies from about 380 nm to about 500 nm) to treat tissue or bones disorders, including osteomyelitis, by a flexible fiber are provided, where the light is delivered in a circumferential fashion around the fiber, and where the energy delivered from the fiber is of a similar average intensity at the front end and back end of the fiber, and in between. The methods and systems deliver intramedullary light to the canal over long lengths via a minimally invasive pathway to a bone. The methods and systems deliver and maintain a light delivery system within the canal of the bone to provide single or multiple doses of light to kill, eliminate, remove or reduce bacteria, viruses, fungus and pathogens, without removal of the light fiber system, thereby providing single or multiple treatments.

Claims (36)

1. A system for providing treatment to tissue, comprising:

a delivery catheter having an elongated shaft and an inner lumen therethrough; and

one or more optical fibers sized to pass through the inner lumen of the delivery catheter and being configured to deliver light energy to provide an antimicrobial effect to the tissue, the one or more optical fibers being configured to disperse the light energy such that intensity of the light energy is distributed evenly over a length of the one or more optical fibers in both longitudinal and circumferential directions;

wherein the one or more optical fibers include a cladding covering an outer surface thereof, and wherein at least a portion of the cladding of the one or more optical fibers is removed from an outer surface of the one or more optical fibers to achieve the even dispersion of the light energy,

wherein the at least a portion of the cladding is removed to form a helical spiral along the length of the one or more optical fibers, wherein the helical spiral becoming increasingly tight as the helical spiral moves from a proximal end of the one or more optical fibers to a distal end of the one or more optical fibers to achieve an even light distribution over the length of the one or more optical fibers,

wherein the antimicrobial effect of the light energy is configured to kill bacteria to treat bone infections.

2. The system of claim 1 , wherein the one or more optical fibers include a cladding covering an outer surface thereof, and wherein at least a portion of the cladding of the one or more optical fibers is removed from an outer surface of the one or more optical fibers to achieve the even dispersion of the light energy.

3. The system of claim 2 , wherein the at least a portion of the cladding is removed to form a helical spiral along the length of the one or more optical fibers.

4. The system of claim 3 , wherein the helical spiral allows for dispersion of light energy around 360 degrees of the one or more optical fibers.

5. The system of claim 1 , wherein the one or more optical fibers includes a diffusive membrane disposed on an outer surface thereof, the diffusive membrane configured to be applied to the outer surface of the one or more optical fibers to achieve the even light distribution over the length of the one or more optical fibers.

6. The system of claim 1 , wherein the light energy has illumination wavelengths from about 400 nm to about 475 nm.

7. The system of claim 1 , wherein the light energy has illumination wavelengths from about 380 nm to about 500 nm.

8. The system of claim 1 , wherein the light energy has illumination wavelengths from about 405 nm to about 470 nm.

9. A system for providing treatment to tissue, comprising:

a light source configured to provide light energy at a plurality of frequencies;

a delivery catheter having an elongated shaft and an inner lumen therethrough; and

one or more optical fibers sized to pass through the inner lumen of the delivery catheter and being configured to deliver the light energy from the light source to provide an antimicrobial effect to the tissue, the one or more optical fibers being configured to disperse the light energy such that intensity of the light energy is distributed evenly over a length of the one or more optical fibers in both longitudinal and circumferential directions;

wherein the one or more optical fibers include a cladding covering an outer surface thereof, and wherein at least a portion of the cladding of the one or more optical fibers is removed from an outer surface of the one or more optical fibers to achieve the even dispersion of the light energy,

wherein the at least a portion of the cladding is removed to form a helical spiral along the length of the one or more optical fibers, wherein a depth of the removal of the cladding increases as the helical spiral moves from a proximal end of the one or more optical fibers to a distal end of the one or more optical fibers to achieve an even light distribution over the length of the one or more optical fibers, and

wherein the antimicrobial effect of the light energy is configured to reduce an amount of one or more pathogens in a bone.

10. The system of claim 9 , wherein the plurality of frequencies of the light energy are selected based on the antimicrobial effect on specific microbial targets for each of the plurality of frequencies of light energy.

11. The system of claim 10 , wherein a subset of the plurality of frequencies of light energy can be used based on the specific microbial targets.

12. The system of claim 9 , wherein the light energy has illumination wavelengths from about 400 nm to about 475 nm.

13. The system of claim 9 , wherein the light source is in the form of a chain of a plurality of LEDs such that the chain of the plurality of LEDs can produce even light dispersion over a length of the chain.

14. A system for providing treatment to tissue, comprising:

a light source configured to provide light energy having a selected power associated therewith;

a delivery catheter having an elongated shaft and an inner lumen therethrough; and

one or more optical fibers configured to include a cladding covering an outer surface thereof and sized to pass through the inner lumen of the delivery catheter and being configured to deliver the light energy from the light source to provide an antimicrobial effect to the tissue, the one or more optical fibers being configured to disperse the light energy such that intensity of the light energy is distributed evenly over a length of the one or more optical fibers with an even power distribution over the length of the one or more optical fibers based on the selected power,

wherein a portion of the cladding is removed in a helical spiral that is configured to become increasingly tight as the helical spiral moves from a proximal end of the one or more optical fibers to a distal end of the one or more optical fibers to achieve an even light distribution over the length of the one or more optical fibers.

15. The system of claim 14 , wherein the light energy is evenly dispersed over the length of the one or more optical fibers in both longitudinal and circumferential directions.

16. The system of claim 14 , wherein the light source comprises a plurality of frequencies of the light energy.

17. A system for providing treatment to tissue, comprising:

a delivery catheter having an elongated shaft and an inner lumen therethrough; and

one or more optical fibers sized to pass through the inner lumen of the delivery catheter and being configured to deliver light energy to provide an antimicrobial effect to the tissue, the one or more optical fibers being configured to disperse the light energy such that intensity of the light energy is distributed evenly over a length of the one or more optical fibers in both longitudinal and circumferential directions;

wherein the one or more optical fibers include a cladding covering an outer surface thereof, and wherein at least a portion of the cladding of the one or more optical fibers is removed from an outer surface of the one or more optical fibers to form a helical spiral along the length of the one or more optical fibers, wherein a depth of the removal of the cladding increases as the helical spiral moves from a proximal end of the one or more optical fibers to a distal end of the one or more optical fibers to achieve the even dispersion of the light energy,

wherein the antimicrobial effect of the light energy is configured to kill bacteria to treat bone infections.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2024
From: RABINER, ROBERT A.; RABINER, LIANE J.; DIPOTO, GENE P.; O'LEARY, ANTHONY W.; MOGUL, MICHAEL P.
To: ILLUMINOSS MEDICAL, INC.
Reel/Frame 067307/0875 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2024
From: ILLUMINOSS MEDICAL, INC.
To: ABL MEDICAL INC.
Reel/Frame 067308/0078 →
Continuity (4)
Continuation 17896902 · Aug 26, 2022
Provisional Application 63264174 · Nov 17, 2021
Provisional Application 63238104 · Aug 27, 2021
Related Publication 20240058483A1 · Feb 22, 2024
References Cited (155)
US 5443495A · Buscemi et al. · 1995 [cited by applicant]
US 5445608A · Chen et al. · 1995 [cited by applicant]
US 5607419A · Amplatz et al. · 1997 [cited by applicant]
US 5620438A · Amplatz et al. · 1997 [cited by applicant]
US 5730719A · Edwards · 1998 [cited by applicant]
US 5800379A · Edwards · 1998 [cited by applicant]
US 5930424A · Heimberger et al. · 1999 [cited by applicant]
US 7806900B2 · Rabiner · 2010 [cited by applicant]
US 7811284B2 · Rabiner · 2010 [cited by applicant]
US 7811290B2 · Rabiner · 2010 [cited by applicant]
US 7842040B2 · Rabiner et al. · 2010 [cited by applicant]
US 7843328B2 · Redmond et al. · 2010 [cited by applicant]
US 7879041B2 · Rabiner et al. · 2011 [cited by applicant]
US 8012157B2 · Chang et al. · 2011 [cited by applicant]
US 8210729B2 · O'Leary et al. · 2012 [cited by applicant]
US 8226659B2 · Rabiner et al. · 2012 [cited by applicant]
US 8246628B2 · Rabiner · 2012 [cited by applicant]
US 8308749B2 · Johnson et al. · 2012 [cited by applicant]
US 8328402B2 · O'Leary et al. · 2012 [cited by applicant]
US 8348956B2 · Rabiner · 2013 [cited by applicant]
US 8366711B2 · Rabiner et al. · 2013 [cited by applicant]
US 8403968B2 · Rabiner et al. · 2013 [cited by applicant]
US 8431074B2 · Neer · 2013 [cited by applicant]
US 8475732B2 · Simmons et al. · 2013 [cited by applicant]
US 8512338B2 · Rabiner et al. · 2013 [cited by applicant]
US 8523901B2 · Rabiner et al. · 2013 [cited by applicant]
US 8574233B2 · Rabiner et al. · 2013 [cited by applicant]
US 8668701B2 · Rabiner et al. · 2014 [cited by applicant]
US 8672982B2 · Rabiner et al. · 2014 [cited by applicant]
US 8684965B2 · Rabiner et al. · 2014 [cited by applicant]
US 8734460B2 · Rabiner et al. · 2014 [cited by applicant]
US 8777950B2 · Colleran et al. · 2014 [cited by applicant]
US 8870965B2 · Rabiner et al. · 2014 [cited by applicant]
US 8906030B2 · Rabiner et al. · 2014 [cited by applicant]
US 8906031B2 · Rabiner et al. · 2014 [cited by applicant]
US 8915966B2 · Rabiner et al. · 2014 [cited by applicant]
US 8936382B2 · O'Leary et al. · 2015 [cited by applicant]
US 8936644B2 · Rabiner et al. · 2015 [cited by applicant]
US 8939977B2 · DiPoto et al. · 2015 [cited by applicant]
US 9005254B2 · Rabiner et al. · 2015 [cited by applicant]
US 9050079B2 · Rabiner et al. · 2015 [cited by applicant]
US 9101419B2 · Colleran et al. · 2015 [cited by applicant]
US 9125706B2 · Rabiner et al. · 2015 [cited by applicant]
US 9144442B2 · Rabiner et al. · 2015 [cited by applicant]
US 9179959B2 · Rabiner et al. · 2015 [cited by applicant]
US 9216049B2 · Rabiner et al. · 2015 [cited by applicant]
US 9254156B2 · Rabiner · 2016 [cited by applicant]
US 9254195B2 · Rabiner et al. · 2016 [cited by applicant]
US 9265549B2 · Rabiner · 2016 [cited by applicant]
US 9427289B2 · Rabiner et al. · 2016 [cited by applicant]
US 9433450B2 · Rabiner et al. · 2016 [cited by applicant]
US 9808647B2 · Rhodes et al. · 2017 [cited by applicant]
US 9999456B2 · Powell et al. · 2018 [cited by applicant]
US 10226642B2 · Rabiner et al. · 2019 [cited by applicant]
US 10238890B2 · Rhodes et al. · 2019 [cited by applicant]
US 10307612B2 · Barneck et al. · 2019 [cited by applicant]
US 10471277B2 · Rhodes et al. · 2019 [cited by applicant]
US 10543338B2 · Barneck et al. · 2020 [cited by applicant]
US 10729916B2 · Barneck et al. · 2020 [cited by applicant]
US 10870015B2 · Barneck et al. · 2020 [cited by applicant]
US 10894173B2 · Barneck et al. · 2021 [cited by applicant]
US 11154724B2 · Rabiner et al. · 2021 [cited by applicant]
US 11229728B1 · Barneck et al. · 2022 [cited by applicant]
US 11229808B2 · Barneck et al. · 2022 [cited by applicant]
US 11241585B2 · Long et al. · 2022 [cited by applicant]
US 11259847B2 · Rabiner et al. · 2022 [cited by applicant]
US 20010055462A1 · Seibel · 2001 [cited by applicant]
US 20020091424A1 · Biel · 2002 [cited by applicant]
US 20030055483A1 · Gumm · 2003 [cited by applicant]
US 20030093145A1 · Lawrence-Brown et al. · 2003 [cited by applicant]
US 20040166018A1 · Clark et al. · 2004 [cited by applicant]
US 20050101854A1 · Larson et al. · 2005 [cited by applicant]
US 20060004317A1 · Mauge et al. · 2006 [cited by applicant]
US 20060100547A1 · Rabiner et al. · 2006 [cited by applicant]
US 20070255287A1 · Rabiner · 2007 [cited by applicant]
US 20080039770A1 · Francis et al. · 2008 [cited by applicant]
US 20080039854A1 · Rabiner · 2008 [cited by applicant]
US 20080125784A1 · Rabiner et al. · 2008 [cited by applicant]
US 20090048629A1 · Rabiner · 2009 [cited by applicant]
US 20090054900A1 · Rabiner et al. · 2009 [cited by applicant]
US 20090112196A1 · Rabiner et al. · 2009 [cited by applicant]
US 20090171358A1 · Chang et al. · 2009 [cited by applicant]
US 20090177204A1 · Colleran et al. · 2009 [cited by applicant]
US 20090187192A1 · Rabiner et al. · 2009 [cited by applicant]
US 20100160838A1 · Krespi · 2010 [cited by applicant]
US 20100234925A1 · Harris et al. · 2010 [cited by applicant]
US 20100256641A1 · Rabiner et al. · 2010 [cited by applicant]
US 20100262069A1 · Rabiner et al. · 2010 [cited by applicant]
US 20100262188A1 · Rabiner et al. · 2010 [cited by applicant]
US 20100265733A1 · O'Leary et al. · 2010 [cited by applicant]
US 20100268151A1 · Mauge et al. · 2010 [cited by applicant]
US 20100331850A1 · Rabiner · 2010 [cited by applicant]
US 20110004213A1 · Rabiner et al. · 2011 [cited by applicant]
US 20110009871A1 · Rabiner · 2011 [cited by applicant]
US 20110046746A1 · Rabiner et al. · 2011 [cited by applicant]
US 20110098713A1 · Rabiner et al. · 2011 [cited by applicant]
US 20110213339A1 · Bak · 2011 [cited by applicant]
US 20110313356A1 · Rabiner et al. · 2011 [cited by applicant]
US 20120065643A1 · Rabiner et al. · 2012 [cited by applicant]
US 20120100601A1 · Simmons et al. · 2012 [cited by applicant]
US 20120150190A1 · Rabiner · 2012 [cited by applicant]
US 20120165941A1 · Rabiner et al. · 2012 [cited by applicant]
US 20120262939A1 · O'Leary et al. · 2012 [cited by applicant]
US 20120275180A1 · Button · 2012 [cited by examiner]
US 20120289968A1 · Rabiner · 2012 [cited by applicant]
US 20130003406A1 · O'Leary et al. · 2013 [cited by applicant]
US 20130006304A1 · Rabiner et al. · 2013 [cited by applicant]
US 20130013008A1 · Rabiner et al. · 2013 [cited by applicant]
US 20130013009A1 · Colleran et al. · 2013 [cited by applicant]
US 20130013010A1 · Rabiner et al. · 2013 [cited by applicant]
US 20130023876A1 · Rabiner et al. · 2013 [cited by applicant]
US 20130023877A1 · Rabiner et al. · 2013 [cited by applicant]
US 20130023886A1 · Rabiner et al. · 2013 [cited by applicant]
US 20130041472A1 · Rabiner et al. · 2013 [cited by applicant]
US 20130046390A1 · Rabiner et al. · 2013 [cited by applicant]
US 20130066326A1 · Rabiner et al. · 2013 [cited by applicant]
US 20130158607A1 · Rabiner et al. · 2013 [cited by applicant]
US 20130184715A1 · Rabiner et al. · 2013 [cited by applicant]
US 20130274549A1 · Natale et al. · 2013 [cited by applicant]
US 20130310875A1 · Rabiner et al. · 2013 [cited by applicant]
US 20130323120A1 · Ma · 2013 [cited by applicant]
US 20140018806A1 · DiPoto et al. · 2014 [cited by applicant]
US 20140135847A1 · Rabiner et al. · 2014 [cited by applicant]
US 20140142581A1 · Rabiner et al. · 2014 [cited by applicant]
US 20140148813A1 · Rabiner et al. · 2014 [cited by applicant]
US 20140163453A1 · Rabiner et al. · 2014 [cited by applicant]
US 20140180288A1 · Rabiner et al. · 2014 [cited by applicant]
US 20140235942A1 · Hellstrom et al. · 2014 [cited by applicant]
US 20150057598A1 · Bornstein · 2015 [cited by applicant]
US 20150066028A1 · Rabiner et al. · 2015 [cited by applicant]
US 20150066085A1 · Rabiner et al. · 2015 [cited by applicant]
US 20150080900A1 · Rabiner et al. · 2015 [cited by applicant]
US 20150088268A1 · Rabiner et al. · 2015 [cited by applicant]
US 20150231287A1 · Lin et al. · 2015 [cited by applicant]
US 20150374498A1 · Rabiner et al. · 2015 [cited by applicant]
US 20160022333A1 · Rabiner et al. · 2016 [cited by applicant]
US 20160128750A1 · Rabiner et al. · 2016 [cited by applicant]
US 20160128836A1 · Rabiner et al. · 2016 [cited by applicant]
US 20160151639A1 · Scharf et al. · 2016 [cited by applicant]
US 20170128742A1 · Rabiner et al. · 2017 [cited by applicant]
US 20190168023A1 · Eltorai · 2019 [cited by applicant]
US 20190175938A1 · Rezaie · 2019 [cited by examiner]
US 20200000504A1 · Rabiner · 2020 [cited by examiner]
US 20200206529A1 · Rhodes et al. · 2020 [cited by applicant]
US 20200397453A1 · McGowan et al. · 2020 [cited by applicant]
US 20220000527A1 · Rabiner et al. · 2022 [cited by applicant]
US 20220134129A1 · Rabiner et al. · 2022 [cited by applicant]
US 20230077399A1 · Rabiner et al. · 2023 [cited by applicant]
CA 3071998A1 · 2019 [cited by applicant]
EP 3370739B1 · 2021 [cited by applicant]
WO WO2012148746A1 · 2012 [cited by applicant]
WO WO2015006309A1 · 2015 [cited by applicant]
WO WO2016079365 · 2016 [cited by applicant]
WO WO2023028342 · 2023 [cited by applicant]
International Search Report;PCT/US22/41745; Nov. 22, 2022; By: Authorized Officer Shane Thomas. [cited by applicant]